# Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA

> **NCT03499678** · — · TERMINATED · sponsor: **HKGepitherapeutics** · enrollment: 81 (actual)

## Conditions studied

- Lung Cancer
- Lung Cancer, Nonsmall Cell
- Lung Cancer, Small Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03499678
- **Lead sponsor:** HKGepitherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-07-19
- **Final completion:** 2019-07-19
- **Target enrollment:** 81 (ACTUAL)
- **Why stopped:** Encountered technical issues with blood plasma samples received from the hospital.
- **Last updated:** 2023-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499678, "Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03499678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*